255 related articles for article (PubMed ID: 34049260)
1. The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A qualitative systematic review and thematic synthesis.
Peddie N; Agnew S; Crawford M; Dixon D; MacPherson I; Fleming L
Breast; 2021 Aug; 58():147-159. PubMed ID: 34049260
[TBL] [Abstract][Full Text] [Related]
2. The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A quantitative systematic review.
Fleming L; Agnew S; Peddie N; Crawford M; Dixon D; MacPherson I
Breast; 2022 Aug; 64():63-84. PubMed ID: 35609380
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer patients' experiences of adherence and persistence to oral endocrine therapy: A qualitative evidence synthesis.
Clancy C; Lynch J; OConnor P; Dowling M
Eur J Oncol Nurs; 2020 Feb; 44():101706. PubMed ID: 32007696
[TBL] [Abstract][Full Text] [Related]
4. Breast Cancer Survivors' Lived Experience of Adjuvant Hormone Therapy: A Thematic Analysis of Medication Side Effects and Their Impact on Adherence.
Ibrar M; Peddie N; Agnew S; Diserholt A; Fleming L
Front Psychol; 2022; 13():861198. PubMed ID: 35602711
[TBL] [Abstract][Full Text] [Related]
5. Understanding adjuvant endocrine therapy persistence in breast Cancer survivors.
Lambert LK; Balneaves LG; Howard AF; Chia SK; Gotay CC
BMC Cancer; 2018 Jul; 18(1):732. PubMed ID: 29996816
[TBL] [Abstract][Full Text] [Related]
6. Adherence to adjuvant endocrine therapy among breast cancer survivors: a systematic review and meta-synthesis of the qualitative literature using grounded theory.
AlOmeir O; Patel N; Donyai P
Support Care Cancer; 2020 Nov; 28(11):5075-5084. PubMed ID: 32601852
[TBL] [Abstract][Full Text] [Related]
7. Deconstructing Decisions to Initiate, Maintain, or Discontinue Adjuvant Endocrine Therapy in Breast Cancer Survivors: A Mixed-Methods Study.
Bluethmann SM; Murphy CC; Tiro JA; Mollica MA; Vernon SW; Bartholomew LK
Oncol Nurs Forum; 2017 May; 44(3):E101-E110. PubMed ID: 28635973
[TBL] [Abstract][Full Text] [Related]
8. Understanding tamoxifen adherence in women with breast cancer: A qualitative study.
Moon Z; Moss-Morris R; Hunter MS; Hughes LD
Br J Health Psychol; 2017 Nov; 22(4):978-997. PubMed ID: 28850763
[TBL] [Abstract][Full Text] [Related]
9. Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review.
Lambert LK; Balneaves LG; Howard AF; Gotay CC
Breast Cancer Res Treat; 2018 Feb; 167(3):615-633. PubMed ID: 29110151
[TBL] [Abstract][Full Text] [Related]
10. Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review.
Murphy CC; Bartholomew LK; Carpentier MY; Bluethmann SM; Vernon SW
Breast Cancer Res Treat; 2012 Jul; 134(2):459-78. PubMed ID: 22689091
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing medication-taking behaviour with adjuvant endocrine therapy in women with breast cancer: A qualitative systematic review.
Xu H; Zhang XJ; Wang DQ; Xu L; Wang AP
J Adv Nurs; 2020 Feb; 76(2):445-458. PubMed ID: 31657028
[TBL] [Abstract][Full Text] [Related]
12. Psychosocial factors in adjuvant hormone therapy for breast cancer: an emerging context for adherence research.
Van Liew JR; Christensen AJ; de Moor JS
J Cancer Surviv; 2014 Sep; 8(3):521-31. PubMed ID: 24986227
[TBL] [Abstract][Full Text] [Related]
13. Adherence to adjuvant tamoxifen and associated factors in breast cancer survivors.
Uslu Y; Kocatepe V; Sezgin DS; Uras C
Support Care Cancer; 2023 Apr; 31(5):285. PubMed ID: 37079089
[TBL] [Abstract][Full Text] [Related]
14. Patients' Experience of Medication Brand Changes during Hormone Therapy for Breast Cancer-An Interpretative Phenomenological Analysis.
Eraso Y; Moon Z; Steinberga I
Healthcare (Basel); 2022 Dec; 10(12):. PubMed ID: 36554081
[TBL] [Abstract][Full Text] [Related]
15. The experiences of adjuvant endocrine therapy for women breast cancer survivors: A literature review.
Long Y; Xie S; Liu Q; Xu F; Li Q; Wang N; Zhang Y
Medicine (Baltimore); 2023 Dec; 102(51):e36704. PubMed ID: 38134074
[TBL] [Abstract][Full Text] [Related]
16. A hard pill to swallow: a qualitative study of women's experiences of adjuvant endocrine therapy for breast cancer.
Harrow A; Dryden R; McCowan C; Radley A; Parsons M; Thompson AM; Wells M
BMJ Open; 2014 Jun; 4(6):e005285. PubMed ID: 24928595
[TBL] [Abstract][Full Text] [Related]
17. Impact of web application support versus standard management on adherence with adjuvant hormone therapy in patients treated for breast cancer: the WEBAPPAC study.
Gernier F; Grellard JM; Dupont C; Castel H; Fernette M; Lahaye F; Charles RM; Leroux T; Ory C; Faveyrial A; Morel A; Emile G; Levy C; Segura C; Allouache D; Johnson A; Geffrelot J; Gunzer K; Lelaidier A; Girault G; Dubot-Poitelon C; San C; Lequesne J; Clarisse B
BMC Cancer; 2023 Aug; 23(1):736. PubMed ID: 37559004
[TBL] [Abstract][Full Text] [Related]
18. Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence?
Ekinci E; Nathoo S; Korattyil T; Vadhariya A; Zaghloul HA; Niravath PA; Abughosh SM; Trivedi MV
J Cancer Surviv; 2018 Jun; 12(3):348-356. PubMed ID: 29396760
[TBL] [Abstract][Full Text] [Related]
19. Behavioral Interventions to Enhance Adherence to Hormone Therapy in Breast Cancer Survivors: A Systematic Literature Review.
Hurtado-de-Mendoza A; Cabling ML; Lobo T; Dash C; Sheppard VB
Clin Breast Cancer; 2016 Aug; 16(4):247-255.e3. PubMed ID: 27133733
[TBL] [Abstract][Full Text] [Related]
20. Systematic adaptation of the adherence improving self-management strategy to support breast cancer survivors' adherence to adjuvant endocrine therapy: An intervention mapping approach.
Janssen AM; Dam J; Prins J; Buffart LM; de Bruin M
Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13721. PubMed ID: 36263723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]